CTT Pharmaceutical Holdings, Inc. cash flow statement CTTH

Annual Quarterly

In the fiscal 2026 year to date through Jun 30, 2026, CTT Pharmaceutical Holdings, Inc. used $26,129 of cash from operations.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jun 30, 2026	Q2 FY2026 YTD Jun 30, 2026	Q3 FY2015 Sep 30, 2015	Q2 FY2015 Jun 30, 2015	Q1 FY2015 Mar 31, 2015	Q4 FY2014 Dec 31, 2014	Q3 FY2014 Sep 30, 2014	Q2 FY2014 Jun 30, 2014	Q1 FY2014 Mar 31, 2014
Operating
Stock-based compensation	—	—	0	0	0	—	—	—	—
Operating cash flow	—	-0	-0 +35.9%	-0 -1.5%	-0 -11915.8%	-0 -22310.0%	-0 +0.7%	-0 +15.2%	-0 +99.6%
Investing
Investing cash flow	—	—	—	—	—	—	0 +748.9%	-0 -748.1%	0 -64.6%
Financing
Financing cash flow	—	0	-0 +80.3%	0 -99.3%	0 +485.6%	—	-0	0	0
Change in cash
Effect of exchange rate	—	—	0 +318.3%	-0	0	0	-0	—	—

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: CTTH (OTC)
Fiscal year ends: December 31
Incorporated in: FL
Headquarters: Tampa, FL
SEC filer status: Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK: 1035422
Former names: Mindesta Inc. (until Jul 21, 2015); INDUSTRIAL MINERALS INC (until Jul 18, 2011); PNW CAPITAL INC (until May 21, 2002); WINCHESTER MINING CORP (until May 26, 2000)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.